Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections: An Evidence-Based Review

Core Evidence - New Zealand
doi 10.2147/ce.s51284
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited